Anti-reflux medicationJuvenile systemic scleroderma (jSSc)jSScanti-reflux therapyNational Registry of Childhood-Onset Scleroderma (NRCOS)
…er among those with ILD, although many within the normal range. Anti-reflux medication use was more frequent in ILD patients (69% vs. 43%, p=0.02), an…